Nicotine derivatives that enhance cognitive function

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546281, 546282, C07D40104, A61K 3144

Patent

active

052781763

ABSTRACT:
Selective and potent nicotinic agonists of the formula: ##STR1## including pharmaceutically-acceptable salts or prodrugs thereof, useful in the treatment of dementias, attentional hyperactivity disorder, anxiety associated with cognitive impairment, or substance abuse withdrawal characterized by decreased cholinergic function.

REFERENCES:
patent: 4332945 (1982-06-01), Edwards
Murphy J. Biol. Chem. 1973, 248, 2796-800.
Clark et al. Principles of Psychopharmacology 1970 p. 166.
Rueppel et al. J.A.C.S. 1971, 93, 7021-8.
Merck Index Eleventh edition pp. 1281-1283.
Acheson et al. J. Chem. Soc. Perkin. Trans. 1980, 1: 579-85.
Wade J. R. Organic Chemistry p. 349, 1987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nicotine derivatives that enhance cognitive function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nicotine derivatives that enhance cognitive function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotine derivatives that enhance cognitive function will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1631577

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.